Circio logoCircio logo

  • About
      • About Circio
      • Pipeline
      • Management Team
      • Board of Directors
      • Careers
      • The Norwegian Transparency Act
  • circRNA
      • Circio AB
      • circVec platform
  • Clinical programs
      • ONCOS-102
      • KRAS program
      • Publications
  • Partnering
  • Investors
      • Press releases
      • Events
      • Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Code of Conduct
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
        • General Meetings
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Articles of Association
      • Contact
  • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
  • Contacts
    • About
      • About Circio
      • Our pipeline
      • Management Team
      • Board of Directors
      • Careers
      • The Norwegian Transparency Act
    • circRNA
      • Circio AB
      • circVec platform
    • Clinical programs
      • ONCOS-102
      • KRAS program
      • Publications
    • Partnering
      • Partnering
    • Investors
      • Press releases
      • Events
      • Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Code of Conduct
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
      • General Meetings
      • Board of Directors
      • Nomination Committee
      • Committees
      • Management
      • Articles of Association
      • Contact
      • Subscribe
      • Contact
    • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
    • Contacts
      • Offices
      • Investors & Media
    All press releases
    • Press releases - Regulatory
    • Press releases - Non-regulatory
    2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • All years
    All subjects
    • Corporate news
    • Other
    September 21, 2023
    Press release - Regulatory

    Circio Holding ASA – Technical adjustment to item 7 in the Notice of the Extraordinary General Meeting to be held on 27 September 2023

    September 21, 2023
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    September 14, 2023
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    September 7, 2023
    Press release - Non-regulatory

    Circio invites to Q&A webcast regarding Extraordinary General Meeting

    September 6, 2023
    Press release - Regulatory

    Circio Holding ASA – Notice of Extraordinary General Meeting

    September 4, 2023
    Press release - Non-regulatory

    ONCOS-102 mesothelioma study published in Journal for ImmunoTherapy of Cancer

    August 24, 2023
    Press release - Regulatory

    Circio Holding ASA – Second Tranche of Convertible Bonds

    August 24, 2023
    Press release - Regulatory

    Circio Holding ASA: First half 2023 results

    August 15, 2023
    Press release - Non-regulatory

    Circio Holding ASA: Invitation to Circio’s first half year 2023 presentation, Thursday 24 August

    June 29, 2023
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    June 26, 2023
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    June 22, 2023
    Press release - Non-regulatory

    Circio: First patient in multiple myeloma trial dosed with TG01 at Oslo University Hospital

    June 15, 2023
    Press release - Non-regulatory

    Circio Holding ASA: June 2022 company update

    June 12, 2023
    Press release - Regulatory

    Circio Holding ASA: Issuance of restricted stock units (RSUs) to the board members

    May 31, 2023
    Press release - Non-regulatory

    Circio invites to a company update on Thursday 15 June 2023

    May 26, 2023
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    May 25, 2023
    Press release - Regulatory

    Circio Holding ASA – New name registered

    May 23, 2023
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    May 22, 2023
    Press release - Regulatory

    Targovax ASA: Minutes from the Annual General Meeting

    May 16, 2023
    Press release - Non-regulatory

    Circio: Link to recording and presentation from Company update 16[th] May 2023

    May 12, 2023
    Press release - Regulatory

    Circio invites to a company update on Tuesday 16 May 2023

    May 3, 2023
    Press release - Regulatory

    Targovax ASA – Correction of the proxy form attached to the notice of the Annual General Meeting

    May 3, 2023
    Press release - Non-regulatory

    Circio: circRNA poster to be presented at the ASGCT Annual Meeting

    April 28, 2023
    Press release - Regulatory

    Targovax ASA – Notice of Annual General Meeting

    April 19, 2023
    Press release - Regulatory

    Targovax to rebrand as Circio, an innovator in next generation circular RNA therapeutics

    April 13, 2023
    Press release - Regulatory

    Targovax ASA: Annual Report 2022

    April 13, 2023
    Press release - Non-regulatory

    Targovax ASA: Registration of share capital increase following conversion of convertible bonds

    April 13, 2023
    Press release - Non-regulatory

    Financial calendar

    March 30, 2023
    Press release - Non-regulatory

    Targovax ASA: Requested Conversion of Convertible Bonds

    March 15, 2023
    Press release - Non-regulatory

    Targovax ASA: circRNA poster to be presented at the AACR Annual Meeting

    March 14, 2023
    Press release - Non-regulatory

    Targovax: First patient dosed with TG01 in the USA

    March 9, 2023
    Press release - Regulatory

    Targovax ASA – First Tranche of Convertible Bonds

    March 9, 2023
    Press release - Regulatory

    Targovax ASA: Minutes from the Extraordinary General Meeting

    March 7, 2023
    Press release - Regulatory

    Targovax to prioritize resources on unlocking the potential of its circRNA platform

    March 6, 2023
    Press release - Regulatory

    Targovax ASA – Additional information prior to the Extraordinary General Meeting

    March 6, 2023
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following settlement of restricted stock units

    March 2, 2023
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insiders pertaining to RSUs

    March 2, 2023
    Press release - Regulatory

    Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

    March 1, 2023
    Press release - Regulatory

    Targovax ASA – Additional information prior to the Extraordinary General Meeting

    February 23, 2023
    Press release - Regulatory

    Targovax invites to Q&A webcast regarding convertible bond financing

    February 16, 2023
    Press release - Regulatory

    Targovax ASA – Notice of Extraordinary General Meeting

    February 16, 2023
    Press release - Regulatory

    Targovax ASA: Fourth quarter 2022 results

    February 16, 2023
    Press release - Regulatory

    Targovax announces financing of up to NOK 300m over three years to advance its clinical cancer programs & pre-clinical circular RNA platform

    February 8, 2023
    Press release - Regulatory

    Targovax ASA: Invitation to Targovax’s fourth quarter 2022 presentation, Thursday 16 February

    IR contact
    Dr Lubor Gaal
    Dr Lubor Gaal
    Chief Financial Officer
    lubor.gaal@circio.com
    (+34) 683 343 811
    Renate Birkeli
    Renate Birkeli
    Investor Relations
    renate.birkeli@circio.com
    (+47) 922 61 624
    Circio logo

    Circio Holding ASA is a biotechnology company developing novel circular RNA and immunotherapy medicines.

    • About
    • circRNA
    • Clinical programs
    • Partnering
    • Investors
    • Media
    • Contacts

    CONTACT

    Circio Holding ASA
    Email: contact@circio.com

    • Cookies
    • Privacy policy
    • STAY CONNECTED